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Abstract 
The phytochemical compounds are used mostly in medicine as alternative medicine. Excessive 
cholesterol is removed mainly through conversion to bile acids in mammals, cytochromes P450 initiate 
all quantitatively significant pathways of cholesterol metabolism and bile acid biosynthesis.  
This study was aimed to investigate the possible potency of medicinal plant Epilobium hirsutum L. (EHT) 
extract and its ingredient ellagic acid (EAT) on rat liver cholesterol and bile acid metabolizing enzymes. 
In addition to molecular studies, bioactive compound of EHT extracts was identified using Liquid 
Chromatograph-Mass Spectrometry (LC-MS) technique. The water extracts of EHT and EAT were 
injected intraperitoneally as 37.5 mg/kg and 20 mg/kg for 9 days, respectively. Then, in vivo effects of the 
EHT and EAT extract on rat liver cholesterol and bile acid metabolizing CYPs were analyzed by 
determining protein and mRNA expression levels using western blotting and qRT-PCR techniques, 
respectively. In addition, serum cholesterol level of animals was determined.  EHT caused 0.6, 0.8 and 
0.6 fold decrease in protein expression of CYP7A1, CYP8B1 and CYP7B1, respectively, whereas 1.3 fold 
increase in protein expression of CYP27A1 was observed. EHT caused 2.1, 1.4 and 4.1 fold decrease in 
mRNA expression of CYP7A1, CYP27A1, CYP7B1, respectively. However, mRNA expression of CYP8B1 was 
decreased 2.3 fold by EHT treatment.  EAT led to 0.7, 0.8 and 0.8 fold decrease in protein expression of 
CYP27A1, CYP8B1, CYP7B1, respectively, but one fold increase of protein expression of CYP7A1. EAT 
caused 2.6, 1.7, 1.8 and 2.3 fold increase in mRNA expression of CYP7A1, CYP27A1, CYP8B1 and CYP7B1, 
respectively.  
EHT-treated and EAT-treated animals also showed a significant reduction in total cholesterol level 
compared to control animals. Based on doses used that applied in this study, EHT and EAT is quite safe 
and can be used for drug development without any toxicity. 
Keywords: Epilobium hirsutum L., ellagic acid, bile acid metabolizing enzymes, cholesterol
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Introduction 
Phytochemicals known as non-nutritive active 
compounds are found naturally in plants, and more 
than a thousand of them are known. They are not 
fundamental to human life, but recent research 
showed that they have preventive and curative 
properties.  They act as mimicking hormones and 
antioxidants and stimulating enzymes; they can also 
destroy bacteria, enhance the immune system and 
detoxify carcinogens by activating CYP and phase II 
enzymes. While some phytochemicals work with 
other nutrients such as vitamins, some others work 
alone. 
CYPs play a vital role in biological and clinical 
processes because they possess numerous 
substrates both endogenous compounds including 
steroids and fatty acids, and exogenous compounds 
including drugs, environmental chemicals and 
pollutants [1-12] In mammals, excessive cholesterol is 
removed mainly through conversion to bile acids, 
and cytochromes P450s (P450s or CYPs) initiate all 
quantitatively important pathways of cholesterol 
metabolism and bile acid biosynthesis [Figure 1, 13]. 
The bile acid pathway is essential in maintaining 
normal cholesterol levels. There are two pathways 
namely the classical pathway and the acidic pathway 
involved in bile acid synthesis catalyzed by CYP7A1 
and CYP27A1, respectively. The first and rate-limiting 
enzyme of the neutral (classic) pathway is 
cholesterol 7α-hydroxylase (CYP7A1). Microsomal 
cholesterol 7α-hydroxylase is a hepatic enzyme; 
therefore, this pathway takes place solely in the liver. 
The alternative pathway is initiated by mitochondrial 
CYP27A1 (sterol 27-hydroxylase). Unlike CYP7A1; 
CYP27A1 is a multi-functional mitochondrial enzyme, 
expressed in many tissues such as lung, kidney, liver, 
prostate, brain, small intestine, arterial endothelium, 
skin, fibroblast and macrophages. In 
contradistinction to the neutral pathway, the acidic 
pathway may start in extra-hepatic tissues. Sterol 12 
α-hydroxylase, microsomal cytochrome P450 
(CYP8B1), is essential for the production of cholic 
acid and balance of ratio between cholic acid and 
chenodeoxycholic acid [14-16]. It is a liver specific 
enzyme and has broad substrate specificity. CYP7B1, 
oxysterol 7α-hydroxylase, is present in many tissues 
including brain, lung, liver, prostate and kidney. 
Hydroxylation reaction catalyzed by CYP7B1 can 
occur either in carbon 7- or carbon 6- area. CYP7B1 
participates in 7-alpha-hydroxylation of 25- and 27-
hydroxycholesterol in an alternative pathway of bile 
acid synthesis [9, 17-19]. 
Epilobium hirsutum L.(EHT) is also commonly 
called as great-hairy willow herb, codlins and cream, 
European fireweed, apple-pie and cherry-pie.  
Epilobium hirsutum L., great willow-herb, grows in 
Eurasia, North Africa, Europe, Southern Australia and 
the United States. Epilobium hirsutum L. was used 
traditionally to treat gastrointestinal and prostate 
diseases, menstrual disorder, stomach ulceration, 
gastritis and sleeping disorders [20-23]. Epilobium 
hirsutum L. also has anti-bacterial, anti-microbial, 
anti-exudative, anti-nociceptive, anti-septic and anti-
phlogistic effects [23-27]. There are many medical 
studies to investigate of these biological impacts of 
Epilobium hirsutum. Wojdylo et al. [28] studied 32 
Polish herbs which have rich phenolic content 
including Epilobium hirsutum. They suggested some 
plants have rich phenolic content like Epilobium 
hirsutum could be used a natural antioxidant source. 
Furthermore, to evaluate the anti-tumor action of 
Epilobium hirsutum L. (Onagraceae) and Maclura 
aurantiaca (Moraceae), Wojdylo et al. [28] treated 
mice with these two plants extract. Epilobium 
treated mice showed prolonged the lifetime and the 
highest antioxidant activity. Moreover, because 
phenolic compound can be used as free radical 
scavengers, Ebrahimzadeh et al. [29] detected a 
linear relationship between phenolic content and 
chelation activity. In that research, Epilobium 
hirsutum and Mentha arvensis showed a good 
chelator activity [29]. 
Karakut et all suggested EHT may alter 
expressions of protein and mRNA and activity of drug 
metabolizing enzymes such as CYP1A1 and CYP2E1 
[27]. Then, Celik et al researched effect of EHT on 
drug metabolizing CYP2B, CYP2C, CYP2D and 
CYP3A[12].Their result supports using EHT as herbal 
remedy inhibits drug clearance due to decreasing 
expression and activity of these CYPs. 
Ellagic acid (EAT) is therapeutic agent for many 
diseases and it is found in pomegranate, 
strawberries, cloudberry, blueberry, blackberry, 
grapes, raspberries, cranberries, pecans, walnuts and 
black currants [30]. Ellagic acid in foodstuff is found 
either generally  conjugated with a glycoside moiety 
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or part of ellagitannins [31]. For the first time, Tell [32] 
proposed that ellagic acid has a potent activity of 
anti-carcinogenic and anti-mutagenic by making 
DNA-adduct, which ellagic acid masks binding side of 
DNA in order to protect engagement of carcinogen 
or mutagen agents. Furthermore, it has been showed 
that pomegranate exhibits anti-oxidant activity 
owing to its phytochemical content [33]. Yu et al [33] 
indicated that pomegranate extract has good effects 
in atherosclerotic animals due to presence of ellagic 
acid [33-34]. Pomegrate juice includes not only ellagic 
acid both also pro-estrogenic and estrogenic 
compounds that they have effects on spread and 
growth of prostate tumors. So, it is important to 
create a treatment establish on one compound such 
as ellagic acid for hormone dependent disorder [35]. 
Also, phenolic compounds including ellagic acid can 
help cell to show anti-oxidant defense by inhibiting 
the expression of CYP and NADPH oxidase [36]. 
Larrosa et al. [37] researched apoptotic effect of 
ellagic acid in colon cancer. It has been found that 
ellagic acid induces apoptosis in colon cancer cells. 
According to results taken from studies of human 
bladder cancer, ellagic acid has effects on subcellular 
signaling by inducing p53 and p21, and decreasing 
COX-2 cycling D1 and nuclear factor kappa (NFKB) 
[38]. Moreover, in another investigation, to study 
anti-inflammatory and anti-nociceptive activity of 
ellagic acid, it was been suggested ellagic acid has a 
beneficial effect on inflammatory pathway by 
inhibiting COX (cyclooxygenase), Interleukin (IL) 1-
Beta, mutagen activated protein kinases and tumor 
necrosis factor alpha induced activation of activator 
protein 1, by inducing iNOS (nitric oxide synthetase), 
COX2 [39-40]. 
Methods 
Preparation of Extraction of Epilobium hirsutum L. 
Epilobium hirsutum L. was collected from Gölyaka, 
Düzce, Turkey, 563 m. altitude in June. Air-dried and 
powdered 50 g plant samples for each taxon were 
subjected to maceration in sterile ddH2O by using 
Heidolph mechanic shaker at 300 rpm/minute at RT 
(room temperature) for 8 hours. Plant extracts 
obtained were filtered through Whatman filter 
paper, dried in a freeze dryer (Christ Gamma 2-16 
LSC), and weighed. Then, the extracts of plants were 
gassed with nitrogen to prevent oxygen interaction, 
and held in at -20°C until use for the assays. 
Phenolic Profile of Plant 
Identification and quantification of the bioactive 
compounds of EHT was carried out by Liquid 
Chromatography Mass Spectrometry (LC-MS) 
(AGILENT 6460 Triple Quadrupole System 
(ESI+Agilent Jet Stream) coupled with AGILENT 1200 
Series HPLC"). For analysis of bioactive compounds 
of EHT extract; ellagic acid, gallic acid, caffeic acid, p-
coumaric acid and quercetin dehydrate were 
selected as standards based on the literature. 
Determination of Total Phenolic Content (TPC)  
Total phenolic content was determined by the 
Folin-Ciocalteu method [41]. EHT extract was diluted 
as 0,2 mg/ml and 0,6 mg/ml.  20 μl of sample was 
mixed with 100 µL of 1:4 diluted % Folin-Ciocalteu’s 
phenol reagent and mixed by pipetting. 80 µL of 10% 
sodium carbonate solution was added in the 96 well 
plate and shaken vigorously. Then, the mixture 
incubated at room temperature for 30 minutes in the 
dark. The absorbance was measured at 750 nm using 
a Multiskan™ GO microplate reader (Thermo 
Scientific, USA). The calibration curve was drawn 
using range of concentrations between 25-200 µg/ml 
gallic acids. The results were expressed in mg gallic 
acid equivalents (GAE)/g fresh matter. The 
experiments were carried out triplicates and 
repeated three times. 
Determination of Total Flavonoid Content (TFC) 
Determination of total flavonoid content was 
performed by colorimetric method of [42] in which 
sodium nitrite reacts with aluminum chloride and 
flavonoids and generates the red color. EHT extracts 
were diluted as 1 mg/ml and 1,5 mg/ml. 20 µL of each 
extract was added into 96 well plate containing 80 µL 
of distilled water and then 6 µL of 5% sodium nitrite 
(NaNO2) was added to the wells. Five minutes later, 6 
µL of 10 % aluminium chloride (AlCl3) solution was 
added. After waiting 6 minutes, 40 µL of 1 M sodium 
hydroxide (NaOH) was added and the total volume 
was completed up to 200 µL with distilled water and 
incubated at room temperature for 30 min. The 
absorbance of the mixture was measured at 510 nm 
using a Multiskan™ GO microplate reader (Thermo 
Scientific,    USA ).    Total    flavonoid    content    was 
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calculated based on the calibration curve prepared 
by using catechin solutions at concentrations from 50 
to 300 µg/ml. The experiments were carried out 
triplicates and repeated three times. 
Animal Studies 
12 weeks old healthy male Wistar Albino rats 
(Rattus norvegicus) which weighing 200-250 g were 
purchased. The water extract of EHT and its 
ingredient (ellagic acid=EAT) were intraperitoneally 
(i.p.) injected to the rats. For the experiment, animals 
were divided into two groups. Rats in control group 
never made any application, but they were kept 
under the same conditions with other groups during 
the experiment. The water extract of EHT and EAT 
were injected intraperitoneally as 37.5 mg/kg and 20 
mg/kg for 9 days. At the end of the treatment 
protocol given above and after 16 h of fasting, the 
rats were euthanized with decapitation. Blood was 
collected by heart puncture, and the livers were 
isolated and stored at -80 ⁰C till preparation of 
microsomes and mitochondrial fractions.  
Protein Expression Analysis by Western Blotting 
Technique 
Microsomal and S1.5 fractions of the rat livers were 
prepared based on Schenkman and Cinti method 
(1978) [43] as optimized by Şen and Kırıkbakan 
(2004) [44]. The protein concentrations of 
microsomes and S1.5 were determined according to 
the method of Lowry et al. (1951) [45] using BSA 
(Crystalline bovine serum albumin) as the standard. 
In the SDS-PAGE method, proteins were separated in 
4% stacking gel and 8.5% separating gel through a 
discontinuous buffer system. Protein samples were 
diluted with 4X sample dilution buffer in a ratio 1:3 (1 
part buffer and three parts sample) to obtain 2 mg/ml 
of protein. The proteins were transferred to 
nitrocellulose membrane. The membrane was 
incubated with blocking solution (5% nonfat dry milk 
in TBST) for one night. The blot was incubated with 
primary antibody for 2 hours. Before incubation with 
secondary antibody, the blot was washed with TBST 
3 times to remove excessive and nonbinding 
antibody. After 1-hour incubation with secondary 
antibody, the blot was washed again with TBST three 
times for 5 minutes each. The end, the blot was 
incubated with substrate solution (alkaline 
phosphate substrate solution). Finally, the image was 
photographed by a gel imaging instrument which 
based on a computer, (Infinity 3000, Vilber Lourmat, 
Marne-la-Vallee Cedex1, France) through Infinity-
Capt Version 12.9 software. The density of protein 
bands was quantified using Image J visualization 
software (Scion Image Version Beta 4.0.2). 
mRNA Expression Analysis by Quantitative Real 
Time PCR (qRT-PCR) 
The impact of EHT and its ingredient EAT on 
CYP7A1, CYP27A1, CYP8B1 and CYP7B1 gene 
expressions was analyzed by quantitative Real Time 
PCR (qRT-PCR) using Corbett Rotor Gene 6000 
(Corbett life Science, PO Box 435, Concorde, NSW 
2137). Quantitative Real-Time PCR was carried out by 
using Light Cycler FastStart DNA MasterPlus SYBR 
Green I (Roche Applied Science, Basel, Switzerland). 
The assay was performed manufacturer’s protocols.  
5 l PCR-grade water and a sample in which reverse 
transcriptase was omitted during reverse 
transcription, were included in every PCR-run as 
negative controls to confirm that there is no genomic 
DNA contamination in the cDNA samples. After 
addition of 3 l of cDNA, 2 l gene-specific primer for 
CYPs and 12.5 µl Fast Start Universal SYBR Green 
Master (ROX), reaction volume was completed to 25 
µl with RNase-free distilled water. All samples were 
run in triplicates, no template control (NTC) was used 
to determine contamination. GAPDH 
(glyceraldehyde 3-phosphate dehydrogenase), a 
housekeeping gene, was used as an internal 
standard. The primers were designed using NCBI, and 
the blasts were confirmed the based on Rottus 
norvegius. Primer sequences, annealing 
temperatures and product sizes for gene expression 
analysis by real-time PCR were given in Table 1.  
Determination of Total Cholesterol 
 Rat serum total cholesterol levels were 
determined by enzymatic and spectrophotometric 
techniques. Cholesterol is found in two forms in the 
blood as free form or esterified form. In this method, 
enzymes (cholesterol esterase and cholesterol 
oxidase) are very specific to determine the forms of 
cholesterol. Cholesterol esterase converted the 
cholesterol esters into the cholesterol. Next, the 
cholesterol was oxidized by cholesterol oxidase to 
produce ketone cholest-4-en-3-one and hydrogen 
peroxide.   After   the  reaction  between  horseradish 
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peroxidase and hydrogen peroxide, a colored 
compound obtained gave an absorbance at 540-570 
nm.  
Statistical analysis 
Statistical analysis was performed by student t-
test using GraphPad Prism 6.0 statistical software 
package for Windows. Results were expressed as 
means with their Standard derivation (SD) and 
p<0.05 were chosen as a level of significance. 
Results 
LC-MS Analysis of Epilobium hirsutum L. 
Recently, Liquid chromatography-Mass 
Spectrometry (LC-MS) has attained popularity owing 
to its specificity and sensitivity. This has made it an 
essential tool for analyzing the pharmacological 
profiles of herbs. EHT extract was analyzed and 
quantified for the presence of 5 phenolic compounds 
(Table 2), including ellagic acid, gallic acid, caffeic 
acid, p-coumaric acid, and quercetin dehydrate. LC-
MS chromatogram of the EHT extract and 4 phenolic 
compounds are presented in Fig. 2, while the 
chromatogram of ellagic acid is shown in Fig. 3 since 
it was analyzed using different column and solvent 
system. According to quantitative LC-MS analysis, 
gallic acid (11.906 ppm) was the major compound 
among the standard phenolics used in this study in 
EHT p-coumaric acid amount was 1.0642 ppm, while 
quercetin dehydrate was less than 0.625 ppm, and 
the ellagic acid value was calculated less than 0.31 
ppm.  
Total Phenolic and Flovanoid Content of Epilobium 
hirsutum L. 
The total phenolic and flavonoid content of EHT 
was determined as defined in Materials and 
Methods. The data represented in Table 2 reveals 
that the total phenolic content of EHT was 225 ±2.123 
mg GAE/g dried extract and the total flavonoid 
content of EHT was 19 mg CE/ g dried extract. 
Effects of EHT and EAT on Rat Liver CYP7A1, CYP27A1, 
CYP8B1, and CYP7B1 Protein Expression 
The impact of EHT and its major ingredients EAT on 
rat liver CYP7A1 (58 kDa), CYP27A1 (60 kDa), CYP8B1 
(57 kDa), and CYP7B1 (58 kDa) protein expression 
were determined via western blot, using 
glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) (37kDa) as an internal control. Fig.4 shows 
the results of Western blot analysis of the CYP 
proteins and GAPDH, with co-immunostaining to 
compare the relative expressions. The intensity of 
immunoreactive protein bands of EHT, EAT and 
control were evaluated with Image J. Relative 
expressions of EHT with reference to housekeeping 
GAPDH protein are illustrated in Fig. 4. The protein 
expressions of CYP7A1, CYP27A1, CYP8B1, and CYP7B1 
in EHT-treated rats were significantly different from 
control rats. EHT caused a 0.6, 0.8, and 0.6 fold 
decrease in protein expression of CYP7A1, CYP8B1, 
and CYP7B1 respectively, and a 1.3 fold increase in 
CYP27A1 (***p<0,0001) (Fig. 4). 
The protein expression levels of CYP27A1 and 
CYP8B1 in ellagic acid-treated rats were significantly 
different from control rats. The densitometric 
analysis of the liver CYP7A1, CYP27A1, CYP8B1, and 
CYP7B1 displayed in Fig.5 shows that EAT caused a 
0.7, 0.8 and 0.8 fold decrease in protein expression 
of CYP27A1, CYP8B1, and CYP7B1 respectively, but a 1 
fold increase of CYP7A1. 
Effects of EHT and EAT on CYP7A1, CYP27A1, CYP8B1, 
and CYP7B1 mRNA Expression 
Changes in mRNA expression of CYP7A1, CYP27A1, 
CYP8B1, and CYP7B1 due to the treatment of EHT and 
EAT were measured by quantitative real-time PCR 
(qRT-PCR). qPCR results of CYP7A1, CYP27A1, CYP8B1, 
and CYP7B1 mRNA levels are presented in Fig. 6. 
GAPDH was used to normalize the results. Livak 
method [46] was applied to determine the mRNA 
expression changes of CYPs. EHT treatment led to 
significant changes in mRNA expression of CYP7A1, 
CYP8B1, and CYP7B1. EHT promoted a 2.1, 1.4 and 4.1 
fold decrease in mRNA expression of CYP7A1, 
CYP27A1, and CYP7B1 respectively, with respect to 
controls and normalized to GAPDH expression as an 
internal reference and a 2.3 fold increase in mRNA 
expression of CYP8B1. 
qRT-PCR data for the effects of EAT on CYP7A1, 
CYP27A1, CYP8B1, and CYP7B1 expression is 
presented in Fig. 7. The relative mRNA expression of 
CYP7A1, CY8B1, and CYP7B1 in ellagic acid-treated rats 
was increased significantly compared to control 
animals. EAT treatment induced a 1.8, 1.3, 2.3, and 2.3 
fold increase in mRNA expression of CYP7A1, 
CYP27A1,   CYP8B1,   and CYP7B1   respectively,   with 
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respect to controls and normalized with GAPDH 
expression as an internal reference. 
Blood Serum Total Cholesterol Levels in Control and 
Treated Rats 
Rat serum total cholesterol levels were 
determined by enzymatic and spectrophotometric 
techniques as described in the Materials and 
Methods section. Serum samples obtained from EHT 
and its major ingredients EAT treated rats were 
determined, and results were given in Table 2. For 
calculation of total cholesterol concentration of 
samples, a standard curve obtained by different 
concentrations of cholesterol was used. EHT ( 
46.25±2.306) and EAT (46±3.572)-treated animals 
showed a significant decrease in total cholesterol 
level compared to control animals (70.5±1.905) (Fig. 
8). 
Discussion 
Until now, two-thirds of the plants identified have 
medicinal importance, and they have been used as a 
medicine for human health and a supplement to the 
maintenance of a healthy lifestyle for centuries. 
Many species of plants have been documented to 
have medicinal properties and beneficial impacts on 
health, especially as antioxidant activity, anti-
carcinogenic potential, anti-microbial, anti-
inflammatory, anti-mutagenic effects and digestive 
stimulation action [47]. 
CYPs (Cytochromes P450 enzymes) play biological 
and clinical vital role because they possess numerous 
substrates both endogenous compounds including 
steroids and fatty acids, and exogenous compounds 
including drugs, environmental chemicals and 
pollutants [48-49, 3-10]. This is the first study to 
demonstrate the in vivo effects of medicinal plant 
EHT and its major ingredients EAT on rat liver bile acid 
metabolizing CYPs (CYP7A1, CYP27A1, CYP8B1 and 
CYP7B1). The water extracts of EHT was injected i.p. 
as 37.5 mg/kg for nine days, respectively. In vivo 
effects of EHT and its major ingredients ellagic acid 
on rat liver bile acid metabolizing CYPs were analyzed 
by determining protein and mRNA expression levels 
using western blotting and qRT-PCR techniques, 
respectively. 
In this study, total cholesterol levels were 
determined by enzymatic and spectrophotometric 
technique. When we compared the total cholesterol 
level of EHT (46.25±2.306) treated animals to control 
(70.5±1.905) in this study, they showed a significant 
decrease in total cholesterol levels. Protein and 
mRNA expressions of bile acid metabolizing enzymes 
were analyzed in EHT-treated samples. According to 
results, EHT caused 0.6, 0.8 and 0.6 fold decrease in 
protein expression of CYP7A1, CYP8B1, CYP7B1, 
respectively, on the contrary, 1.3 fold increase in 
protein expression of CYP27A1. EHT caused 2.1, 1.4 
and 4.1 fold decrease in mRNA expression of CYP7A1, 
CYP27A1, CYP7B1, respectively, with respect to 
controls and normalized to GAPDH expression as an 
internal reference, however, 2.3 fold increase in 
mRNA expression of CYP8B1. Fig. 9 indicates that the 
decrease of CYP27A1 mRNA expression does not 
interpret with a proper decrease of CYP27A1 protein 
levels. Moreover, the increase of CYP8B1 mRNA 
expression does not correlate with a fitting increase 
of CYP8B1 protein expression.  
According to results, EAT caused 0.7, 0.8 and 0.8 
decrease in protein expression of CYP27A1, CYP8B1, 
CYP7B1, respectively, but one fold increase of protein 
expression of CYP7A1. EAT caused 2.6, 1.7, 1.8 and 2.3 
fold increase in mRNA expression of CYP7A1, 
CYP27A1, CYP8B1 and CYP7B1 respectively, with 
respect to controls and normalized with GAPDH 
expression as an internal reference. There is only a 
correlation between relative mRNA and protein 
expressions of ellagic acid-treated CYP7A1 enzyme as 
shown Fig. 9. 
In appears that when mRNA and protein 
expression of CYPs were compared, there was no 
significant correlation. The expressions of CYPs gene 
is regulated transcriptionally, post-transcriptionally, 
translationally and post-translationally. These 
mechanisms are important for steady-state protein 
concentration. There are some reasons for these 
poor correlation or non-correlation. Translation and 
protein degradation are as important as mRNA 
transcription and stability of the final product of 
protein. Transcription is first and major target for 
gene regulation. But transcriptional regulation is not 
enough for describe protein abundance. One of the 
explanation is micro RNA (miRNAs), 21 nucleotide 
long non-coding RNA, mediates gene expressions. 
Generally, miRNAs repress the protein synthesis by 
inhibiting      translation       and/or      via    facilitating 
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deadenylation and following degradation of mRNA 
targets [50]. 
There is a correlation relative to protein and mRNA 
expression of CYP7A1 and CYP7B1 in EHT-treated 
samples. The first and rate-limiting enzyme in the 
neutral pathway is cholesterol 7α-hydroxylase 
(CYP7A1). Bile acids can regulate cholesterol 
homeostasis via bile acid synthesis pathway. Bile acid 
synthesis is regulated by many factors, including bile 
acids, nutrients, diets, and hormones, in particular 
through regulating transcription of CYP7A1 gene. 
Besides, many liver-specific transcription factors, 
commonly nuclear receptors have an important role 
in cholesterol and bile acid metabolism [51-54]. 
A mentioned above, regulating transcription of 
CYP7A1 gene is very important bile acid synthesis. 
LXR and FXR play a crucial role coordinately way on 
bile acid synthesis, transport and absorption in liver 
and intestine, and cholesterol metabolism in the liver 
and peripheral tissues.  When cholesterol increases in 
liver, oxysterols activate LXRα, which stimulates 
conversion of cholesterol to bile acids by inducing 
CYP7A1 transcription. Increased bile acid synthesis 
and pool stimulate FXR, which inhibits CYP7A1 to 
decrease bile acid synthesis but stimulates BSEP (bile 
salt export pump) expression to excrete bile acids 
into bile. Thus, bile acid- regulated genes and nuclear 
receptors are promising target for drug development 
for decreasing the serum cholesterol and 
triacylglycerol levels, and liver and cardiovascular 
diseases [51-52]. 
According to our protein and mRNA expression 
results, EHT repressed the CYP7A1 transcription while 
EAT induced it. Decreased cholesterol level leads to 
repression of CYP7A1 enzyme production. EHT-
treated animals showed a significant reduction in 
total cholesterol levels.  EHT-treated animals also 
showed a decrease in protein and mRNA expression 
of CYP7A1 enzyme, since decreased cholesterol 
suppresses the CYP7A1 enzyme transcription. Our 
data indicates that EHT may affect FXR and BSEP, 
which resulted in activation of FXR and BSEP 
transcriptional activity and thus, inhibition of CYP7A1 
expression. To create the bile acids that are needed 
by the body EHT activates the alternative pathway 
inducing CYP27A1, due to activation of BSEP. 
However, EAT induces production of CYP7A1 which is 
the rate limiting enzyme of classic pathway.  
In conclusion, the synthesis of bile acids from 
cholesterol by CYP-catalyzed reactions can be altered 
due to the changes in CYP protein and mRNA 
expressions which may be resulted by the treatment 
of animals with EHT and EAT. EHT and EAT-treated 
animals showed a significant decrease in total 
cholesterol levels. Also, EHT-treated animals showed 
a decrease in protein and mRNA expression of 
CYP7A1 enzyme, since decreased cholesterol 
suppresses the CYP7A1 enzyme transcription. To 
create the bile acids that are needed by the body EHT 
activates the alternative pathway inducing CYP27A1. 
However, EAT induces production of CYP7A1 which is 
the rate limiting enzyme of classic pathway. 
Therefore, bases on doses and time point that 
applied in this study, the medicinal plant EHT and its 
polyphenolic compound, EAT, may have regulatory 
effects on bile acid metabolizing enzymes. In 
conclusion, the synthesis of bile acids from 
cholesterol by CYP-catalyzed reactions may be 
altered due to the changes in CYP protein and mRNA 
expressions which may be resulted by the treatment 
of animals with EHT and EAT; EHT and EAT is quite 
safe and can be used for drug development without 
any toxicity. 
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Table 1. Primer sequences, annealing temperatures and product sizes for gene expression analysis. 
Gene           Sequence(5'→ 3' ) Annealing 
Temperature (°C) 
Produc
t Size (bp) 
CYP7A1 F→ TGCCTTCTGTTACCGAGTGATGTT 
R→ACCGGCAGGTCATTCAGTTGCACT 
60 518 
CYP27A
1 
F→ ATG TGG CCA ATC TTC TCT ACC 
R→ GGG AAG GAA AGT GAC ATA GAC 
55 163 
CYP8B1 F→ CAGGTTGGAAGCCGAGACAT 
R→ TGCCCACTGGCCATCTTTAG 
60 158 
CYP7B1 F→ CCTTCTCTTTGCGGTCACCT 
R→ TTTCAGGGCCATGCCAAGAT 
60 121 
GAPDH F→ GATGACATCAAGAAGGTGGTGAAG 
R→ TCCTTGGAGGCCATGTGGGCCAT 
60 240 
 
 
Table 1. Quantitative LC-MS analysis of selected bioactive compounds from Epilobium hirsutum L.; and total phenolic and 
flavonoid content of the plant. 
Bioactive compound Epilobium hirsutum L. 
Gallic acid 11,906 ± 0,1810 
Cafeic acid ≤  0,31 ppm 
Quercetin dhydrate ≤  0,625ppm 
p-coumaric acid 1,0642±0,0027 
Ellagic acid ≤  0,31 ppm 
  
Total phenolic content 225±2, 123 (mgGAE/g dried 
extract±SD) 
Total flavonoid 
content 
19,2593±0,8225 (mg CE/g 
dried extract±SD) 
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Figure 1. Synthesis and metabolism of bile acids (Klaassen & Cui 2015) 
 
 
 
 
Figure 2. LC-MS chromatogram of EHT extract. Bright green line shows mixture of standards (total 5 ppm). Dark green line 
shows EHT extract (10 mg/ml). 
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Figure 3. LC-MS chromatogram of EHT extract. Grey line shows 2.5 ppm EAT. Blue line shows EHT extract (10 mg/ml). 
 
 
 
 
Figure 4 (A) Representative immunoblot of liver CYP7A1 (58 kDa), CYP27A1 (60 kDa), CYP8B1 (57 kDa), and CYP7B1 (58 kDa) 
proteins in experimental control and EHT. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (37 kDa) was used as an 
internal standard for each membrane. (B) Comparison of CYP7A1, CYP27A1, CYP8B1, and CYP7B1 protein expression of the 
control (n=21) and EHT treated (n=16) groups. Band quantification was expressed as the mean ±SD of the relative intensity 
with respect to that of GAPDH, used as the internal control. Asterisks denote the level of significance: ***p<0, 0001. 
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Figure 5. (A) Representative immunoblot of liver CYP7A1 (58 kDa), CYP27A1 (60 kDa), CYP8B1 (57 kDa), and CYP7B1 (58 kDa) 
proteins in experimental control and EAT. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (37 kDa) was used as an 
internal standard for each membrane. (B) Comparison of CYP7A1, CYP27A1, CYP8B1, and CYP7B1 protein expression of the 
control (n=6) and EAT treated (n=6) groups. Band quantification was expressed as the mean ±SD of the relative intensity 
with respect to that of GAPDH, used as the internal control. *Significantly different from the respective control value 
p<0.005. 
 
 
 
 
 
Figure 6.Comparison of in vivo effects of EHT on rat liver CYP7A1, CYP27A1, CYP8B1, and CYP7B1 mRNA expression. The 
quantities are expressed as mean ±SD of the relative expression. 
 
 
C
Y
P7
A
1
C
Y
P2
7A
1
C
Y
P8
B
1
C
Y
P7
B
1
0
1
2
3
4
5
CONTROL
TREATED
**
*
***
R
e
la
ti
v
e
 m
R
N
A
 e
x
p
re
s
s
io
n
 
 
PhOL     Ege, et al.    214 (pag 200-215) 
 
 
http://pharmacologyonline.silae.it 
ISSN: 1827-8620 
 
Figure 7: Comparison of in vivo effects of EAT on rat liver CYP7A1, CYP27A1, CYP8B1, and CYP7B1 mRNA expressions. The 
quantities were expressed as mean ±SD of the relative expression. 
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Figure 8. Comparison of blood serum total cholesterol levels between. EHT, EAT treated, and control animals. *Significantly 
different from the respective control value p<0.05. 
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Figure 9. Effects of EHT and EAT on CYP7A1, CYP27A1, CYP8B1 and CYP7B1 protein (I) and mRNA (II) expressions.I: Fold 
change of CYP7A1, CYP27A1, CYP8B1 and CYP7B1 protein expression. II: Fold change of CYP7A1, CYP27A1, CYP8B1 and CYP7B1 
mRNA expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-1.0 -0.5 0.0 0.5 1.0 1.5
CYP7A1
CYP27A1
CYP8B1
CYP7B1
EHT
EAT
-6 -4 -2 0 2 4
CYP7A1
CYP27A1
CYP8B1
CYP7B1
EHT
EAT
I II 
View publication stats
